Tagged Content
Tags > Medication Updates
Year: Medication:  Antipsychotics Cymbalta Farxiga Lunesta Methylphenidate Naloxone/Evzio Olanzapine/Zyprexa Opioids Tanzeum Targiniq ER Tramadol Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide 2014 First-Generation vs Second-Generation Antipsychotics in Adults: Comparative Effectiveness AHRQ clinician summary of systematic review examining their comparative effectiveness, benefits, and adverse effects. FDA approves Targiniq ER Targiniq ER is an extended-release pain reliever with abuse-deterrent properties - contains oxycodone and naloxone. Tramadol placed in Schedule IV of Controlled Substances Act Schedule IV controlled substances regulatory requirements apply to tramadol as of 8/18/14.



View all tags
View RSS XML